| Prefecture |
Organization |
Institute Director |
Introduction of your Technology, Product and Study |
Technology Classification/Product Classification |
Contact |
| Enterprise |
Biomarker Science Co., Ltd
|
Kagehiro Uchida
|
Biomarker Science (BMS) has identified many biomarkers that can be used for assessing disease-onset-risk by extensive pretomics studies. BMS has also developped "LOX index", a novel predictive biomarker for coronary heart disease and stroke (Clinical Cemistry 56: 4, 550-551,2010). BMS has been implementing contract studies to evaluate potential benefits of functional food materials to reduce disease-onset-risk. BMS is aiming to introduce risk-reducing products to people, as well as to show the risks they have. Moreover, BMS is implementing a joint resaech of a stem cell-based regenerative medicine for heart failure to assist commercialization of the technology (two patients have been successfully treated) . |
[Technology Classification]
-A004/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Structure
-BA10/Life Innovation/Drug Discovery & Diagnosis/Diagnostic Equipment
-BB08/Life Innovation/Regenerative Medicine/Heart
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BB04/Life Innovation/Medical Equipment/Medical Supplies
|
+81-6-6943-1011
info@biomarker.co.jp |
| Enterprise |
BioView, Inc
|
Takashi Yokawa
|
BioView was established as an entrusted-tests organization for MRI imaging technology.Our core enterprise is entrusted tests and support for drug discovery and development. For medical implants, we carry out MRI compatibility tests according to ASTM standards. The following are our core technologies and services.We are eager to serve pharmaceutical companies with our technology.1) For experimental use: Tests using 4.7T MRI Evaluation of drug efficacy using rats and mice. Development of contrast agents. Evaluation of foods (discrimination of water and oil) and etc. 2) For medical use: MRI compatibility tests (seeds and technology) Evaluation test according to ASTM standards (existent standard in Europe and United States) for embedded medical implants such as stents. We are the sole company to carry out such evaluations in Japan.3) For clinical use: Test using MRITests using large animals. Entrusted human fMRI tests. It is possible to detect responses of the brain. |
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-78-302-7400
info@bioview.co.jp |
| Enterprise |
Carna Biosciences, Inc.
|
Kohichiro Yoshino
|
[Drug Discovery Support Service]We provide drug discovery supporting products and services:1. Kinase Proteins,2. Profiling Services,3. Assay Development,4. Crystallography.[Drug Discovery and Development Business ]We identify and develop new medicines primarily for the treatment of cancer and anti-inflammatory diseases using our own innovative kinase drug discovery platform, QuickScout(TM). |
[Technology Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Protein Synthesis
-A008/Basic Technology/Basic & Fundamental Technology/Bio Informatics
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-78-302-7039
|
| Enterprise |
GeneDesign, Inc.
|
Technical Support & Marketing Division
Kazuhiko Yuyama
|
Gene Design, Inc. has been developed a bio-research support business with various products such as custom DNA/RNA/LNA oligonucleotide synthesis, and so on. We have launched a new product for metylation analysis called ICON probe. To create novel nucleic acid drug materials, the folloing three R&D pipelines are proceeded, 1) Development of ribbon-type decoy nucleic acid 2) Synthesis method development and application of bridged nucleic acid (BNA) oligonucleotides. 3) Exploitation of the manufacturing system for nucleic acid drugs under GMP control. |
[Technology Classification]
-BA03/Life Innovation/Drug Discovery & Diagnosis/Drugs (Nucleic Acid)
-A001/Basic Technology/Basic & Fundamental Technology/Analysis of Gene Function
[Product Classification]
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-72-640-5180
info@genedesign.co.jp |
| Enterprise |
HiPep Laboratories
|
Kiyoshi Nokihara
|
1. Undertaking peptide synthesis and consulting,2. Carbon substrates for biochips,3. Simplified device for synthesizing peptides,4. Reagents for synthesizing peptides,5. Supplies for synthesizing peptides,6. Undertaking analysis for peptides. |
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-75-813-2101
info@hipep.jp |
| Enterprise |
Hosokawa Micron Corporation
|
Material Business Div. Pharmaceutical & Beauty Science Center
Hiroyuki Tsujimoto
|
The usefulness of PLGA nanoparticales as DDS carriers has been verified in many studies. Our laboratory conducts entrusted research on PLGA nanoparticle designs and drug formulations using our unique "Emulsion Solvent Diffusion Method" which enables sterile and GMP standard manufacturing. We can provide PLGA nanoparticles suited for various customer needs using the knowledge that we have accumulated over the years. |
[Technology Classification]
-BA03/Life Innovation/Drug Discovery & Diagnosis/Drugs (Nucleic Acid)
-BA09/Life Innovation/Drug Discovery & Diagnosis/DDS
-BC10/Life Innovation/Medical Equipment/Catheterization
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-72-855-2231
akubota@hmc.hosokawa.com |
| Enterprise |
JTEC Corporation
|
Bio-Medical Department
Takashi Tsumura
|
With the accumulated knowledge from many years of developing automatic culture systems, JTEC develops many systems using advanced technology: cultivation
fractionation and dispensation
environment control
plate handling with robotics
and more.We design and manufacture cell culture systems according to your protocol and contribute to the efficiency of your R&D.JTEC has achieved to commercialize X-ray KB nano-focusing mirrors with sub-100nm polished by EEM, the ultra smooth polishing technology of Osaka University. We have delivered our state-of -the-art X-ray mirrors to SPring8 in Hyogo and many other Synchrotron facilities in the world. |
[Product Classification]
-A001/Basic Technology/Basic & Fundamental Technology/Equipments
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-78-302-0950
info@j-tec.co.jp |
| Enterprise |
KAJIXX Co., Ltd
|
Takafumi Kajitani
|
We support drug discovery, genomics, and protein research by conducting entrusted weighing and dissolving operations. At our branch in Kyoto, we are developing ways to exploit our technology in the medical, environmental, and health welfare industries. |
[Technology Classification]
-A006/Basic Technology/Basic & Fundamental Technology/Cultivation, Differentiation & Separation of Cell & Tissue
-A004/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Structure
-A001/Basic Technology/Basic & Fundamental Technology/Analysis of Gene Function
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Diagnosis)
|
+81-90-6192-7388
kajitani@kajixx.co.jp |
| Enterprise |
Kaneka Techno Research Corporation
|
Department of material analysis
Takashi Imai
|
Kaneka Techno Research is a subsidiary of Kaneka Corporation, one of the most active bio-related industries, and also a pioneer in the R&D supporting business in Japan. Kaneka Techno Research is now running their business in three fields
1) material analysis, 2) environmental analysis and 3) technical research.About 120 enthusiastic experts are working on solving technical problems utilizing their knowledge and technique, not only for their mother company but also for customers worldwide.All of the customers' secret and personal information shall be kept closed according to their company policy. |
[Technology Classification]
-CA05/Green Innovation/Environment & Energy/Monitoring
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-CA04/Green Innovation/Environment & Energy/Examination of Environmental Pollutants
|
+81-72-653-8300
|
| Enterprise |
KNC Laboratories Co., Ltd.
|
BIO TECHNOLOGY & DRUG DISCOVERY DIVISION
Katsutoshi Hirose
|
KNC aims to develop a new area, i.e. immune system related pharmaceuticals, genome-based drug discovery and etc., in addition to the existing core areas of peptides, oligonucleotides (DNA, RNA), cell-culture and fermentation, extraction and purification, and synthesis of bio-related chemicals. |
[Technology Classification]
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
-BA03/Life Innovation/Drug Discovery & Diagnosis/Drugs (Nucleic Acid)
-BA04/Life Innovation/Drug Discovery & Diagnosis/Drugs (Glyco Protein)
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-78-224-5106
|
| Enterprise |
Protein Wave Corporation
|
R&D Center
Akira Sanjoh
|
On the basis of protein science research initiative, we are focusing on our R&D effort to exploration of mechanism of disease and clinical protection.Inhibiting activity of potential lead compounds in complex with the target protein is further verified by three dimensional X-ray crystal structure analysis.Our business further covers development of several kinds of intelligent tools for research use such as X-ray crystal structure analysis of protein crystals and new materials, as well as distribution of crystal screening reagent kits. |
[Technology Classification]
-A004/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Structure
-BA11/Life Innovation/Drug Discovery & Diagnosis/Bio-tips
-CC02/Green Innovation/Chemicals/Bio Refinery & Bio Process
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-CB01/Green Innovation/Agriculture & Food/Food
|
+81-774-95-5109
asanjoh@pro-wave.co.jp |
| Enterprise |
Sanshodo Co., Ltd.
|
Bio Affairs
Katsumi Dote
|
As a medical, pharmaceutical, nursing care, and biological wholesale company, we are proud to have a wide product variety which covers all of our sales fields. We also have a system which comprehensively supports basic research, product development, market research, and product sales. We are very pleased to serve you. |
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BB01/Life Innovation/Medical Equipment/Diagnostic Equipment
|
+81-75-682-0117
pd@sanshodoh.co.jp |
| Enterprise |
STREX,Inc.
|
Norio Ishida (President/CEO)
|
STREX instruments simulates mechanical stress in cell cultures. Seeded cells grow in strain chambers which are stretched or compressed by the instrument. The mechanical stress applied to the cells better simulates natural dynamic physiological environments. We develop and manufacture laboratory equipment and medical devices used by academic,commercial,and government research laboratories. |
[Technology Classification]
-A006/Basic Technology/Basic & Fundamental Technology/Cultivation, Differentiation & Separation of Cell & Tissue
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-6-6271-9373
info@strex.co.jp |
| University |
Kobe University
|
Laboratory of Biochemistry
Hiroshi Yamagata
|
We are developing a transgenic tomato with different kinds of useful proteins accumulated in the fruit juice by utilizing a strong promoter and coding sequence for a signal peptide of a melon cucumisin gene. For example, we are trying to produce medical supplies such as peptide hormones or various useful enzymes in tomatoes in large quantities. We succeeded in the construction of a tomato introduced with the human interferon alpha gene. |
[Technology Classification]
-A001/Basic Technology/Basic & Fundamental Technology/Analysis of Gene Function
-A003/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Function
-CB02/Green Innovation/Agriculture & Food/GM Crops
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-CB02/Green Innovation/Agriculture & Food/Agriculture
|
+81-78-803-5875
yamagata@kobe-u.ac.jp |
| University |
Osaka Kyoiku University, Department of Natural Sciences
|
Biomolecular Science
Masanao Katagiri (Professor)
|
Our target proteins and genes are cytochrome P450s which catalyzes steroid metabolism, drug metabolism, and antibodies which bind to low molecular weight antigens, such as steroids and metals. |
[Technology Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Function
-A005/Basic Technology/Basic & Fundamental Technology/Metabolism
-CA05/Green Innovation/Environment & Energy/Monitoring
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-CA04/Green Innovation/Environment & Energy/Examination of Environmental Pollutants
|
+81-72-978-3650
katagiri@cc.osaka-kyoiku.ac.jp |
| University |
Ryukoku University
|
Department of Materials Chemistry
Tomohiro Miyatake
|
Cell-penetrative materials and application for optical enzyme assays. We apply cell-penetrative compounds and fluorogenic liposomes to optical transduction of enzyme reactions. We have successfully introduced the optical transducer to universal enzyme assays and to optical sensing of flavors (sucrose, glutamate, etc.) and other biomaterials (lipids, etc). |
[Technology Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Function
-A012/Basic Technology/Basic & Fundamental Technology/Improvement & Search of Functional Enzyme
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-77-543-7467
miyatake@rins.ryukoku.ac.jp |
| University |
Ryukoku University
|
Department of Mechanical and Systems Engineering
Daisuke Tawara
|
We investigate mechanisms of mechanical adaptation in biological objects such as bones and cells using computer simulation and an experimental approach for the development of new machine structure and materials. We focus particularly on the assessment of bone fracture risks, the prediction of change in mechanical properties of bone by its remodeling, and the elucidation of mechanisms of mechano-sensors in actin cytoskeletal structure of a cell. We are looking for collaborators on the development of medical machines, devices, and mechanical evaluation of new materials or biological material. |
[Technology Classification]
-BA08/Life Innovation/Drug Discovery & Diagnosis/in silico Screening
-A006/Basic Technology/Basic & Fundamental Technology/Cultivation, Differentiation & Separation of Cell & Tissue
-BB05/Life Innovation/Regenerative Medicine/Bone & Osteochondral
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-77-543-7504
datawara@rins.ryukoku.ac.jp |
| Institute |
National Institute of Advanced Industrial Science and Technology
|
Health Research Institute
Yasukazu Yoshida
|
We aim to develop technologies for maintaining and enhancing human health and extending healthy life expectancy together with creation of sophisticated medical systems and new industries for health care.The following projects are promoted. Project 1: Development of predictive and diagnostic technologies for health maintenance.Project 2: Health-risk reduction technologies in daily life.Project 3: Technologies for cells and tissue regeneration.Project 4: Sensing for cells' function and manipulation technologies aiming at improved function.Project 5: Non-invasive techniques to measure human cognition and behavior. |
[Technology Classification]
-A006/Basic Technology/Basic & Fundamental Technology/Cultivation, Differentiation & Separation of Cell & Tissue
-BB05/Life Innovation/Regenerative Medicine/Bone & Osteochondral
-A003/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Function
[Product Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Diagnosis)
|
+81-72-751-9520
hri_webmaster@m.aist.go.jp |
